

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.86049248 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75778075 |
| 3 | response to interleukin-15 (GO:0070672) | 4.46055519 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.30928542 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.30928542 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.30928542 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.30928542 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.30928542 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.30928542 |
| 10 | activated T cell proliferation (GO:0050798) | 4.27425336 |
| 11 | negative T cell selection (GO:0043383) | 4.23725505 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.17308011 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 4.12888539 |
| 14 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.03148151 |
| 15 | nuclear pore complex assembly (GO:0051292) | 3.89549027 |
| 16 | detection of other organism (GO:0098543) | 3.88339884 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.87536449 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.87536449 |
| 19 | DNA unwinding involved in DNA replication (GO:0006268) | 3.86135166 |
| 20 | tetrahydrofolate metabolic process (GO:0046653) | 3.84589119 |
| 21 | B cell receptor signaling pathway (GO:0050853) | 3.84447945 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.81270472 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 3.78580517 |
| 24 | detection of bacterium (GO:0016045) | 3.65873646 |
| 25 | nuclear pore organization (GO:0006999) | 3.64928067 |
| 26 | cellular extravasation (GO:0045123) | 3.63510383 |
| 27 | IMP biosynthetic process (GO:0006188) | 3.63370561 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.60342606 |
| 29 | T cell selection (GO:0045058) | 3.49947366 |
| 30 | positive regulation of granulocyte differentiation (GO:0030854) | 3.46820759 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.44716741 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.42506861 |
| 33 | positive T cell selection (GO:0043368) | 3.41717031 |
| 34 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.39272429 |
| 35 | protein localization to kinetochore (GO:0034501) | 3.39102122 |
| 36 | detection of external biotic stimulus (GO:0098581) | 3.37850951 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.34831402 |
| 38 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.33587414 |
| 39 | folic acid metabolic process (GO:0046655) | 3.29542146 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.28904652 |
| 41 | negative regulation of cell killing (GO:0031342) | 3.28904652 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28825245 |
| 43 | positive regulation of mast cell activation (GO:0033005) | 3.28205240 |
| 44 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26496582 |
| 45 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.26459020 |
| 46 | positive thymic T cell selection (GO:0045059) | 3.25805485 |
| 47 | T cell migration (GO:0072678) | 3.24621742 |
| 48 | tolerance induction (GO:0002507) | 3.18194809 |
| 49 | one-carbon metabolic process (GO:0006730) | 3.16513997 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.16513531 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.15672300 |
| 52 | thymic T cell selection (GO:0045061) | 3.14965379 |
| 53 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14544678 |
| 54 | regulation of translational fidelity (GO:0006450) | 3.13329158 |
| 55 | regulation of granulocyte differentiation (GO:0030852) | 3.12434771 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.09055627 |
| 57 | DNA geometric change (GO:0032392) | 3.07700023 |
| 58 | pore complex assembly (GO:0046931) | 3.07381947 |
| 59 | IMP metabolic process (GO:0046040) | 3.06344294 |
| 60 | DNA duplex unwinding (GO:0032508) | 3.06125705 |
| 61 | folic acid-containing compound metabolic process (GO:0006760) | 3.05771686 |
| 62 | response to peptidoglycan (GO:0032494) | 3.05591230 |
| 63 | regulation of defense response to virus by virus (GO:0050690) | 3.03407042 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02650119 |
| 65 | respiratory burst (GO:0045730) | 3.02209385 |
| 66 | glycine metabolic process (GO:0006544) | 3.01104289 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00622352 |
| 68 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.99716338 |
| 69 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.99716338 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.99100814 |
| 71 | response to host immune response (GO:0052572) | 2.98528376 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98528376 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 2.98488467 |
| 74 | translesion synthesis (GO:0019985) | 2.98260419 |
| 75 | heterochromatin organization (GO:0070828) | 2.97294864 |
| 76 | microglial cell activation (GO:0001774) | 2.96969494 |
| 77 | regulation of B cell differentiation (GO:0045577) | 2.95662656 |
| 78 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.95484777 |
| 79 | dosage compensation (GO:0007549) | 2.95273001 |
| 80 | mitotic nuclear envelope disassembly (GO:0007077) | 2.94623582 |
| 81 | neutrophil mediated immunity (GO:0002446) | 2.94511563 |
| 82 | neutrophil activation (GO:0042119) | 2.94070444 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93701954 |
| 84 | regulation of leukocyte degranulation (GO:0043300) | 2.92719523 |
| 85 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.89182966 |
| 86 | regulation of necroptotic process (GO:0060544) | 2.89171211 |
| 87 | detection of biotic stimulus (GO:0009595) | 2.88276118 |
| 88 | histone H3-K9 demethylation (GO:0033169) | 2.87897793 |
| 89 | positive regulation of B cell differentiation (GO:0045579) | 2.87521081 |
| 90 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.85322117 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.84493211 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 2.84493211 |
| 93 | regulation of mast cell activation (GO:0033003) | 2.84199531 |
| 94 | mitotic chromosome condensation (GO:0007076) | 2.83296983 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82951075 |
| 96 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81664275 |
| 97 | DNA replication initiation (GO:0006270) | 2.80522136 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79589932 |
| 99 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.78459225 |
| 100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77774815 |
| 101 | response to host (GO:0075136) | 2.77774815 |
| 102 | response to host defenses (GO:0052200) | 2.77774815 |
| 103 | negative regulation of necroptotic process (GO:0060546) | 2.77266435 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.76682537 |
| 105 | B cell homeostasis (GO:0001782) | 2.76353616 |
| 106 | nuclear envelope disassembly (GO:0051081) | 2.73967172 |
| 107 | membrane disassembly (GO:0030397) | 2.73967172 |
| 108 | regulation of tolerance induction (GO:0002643) | 2.73064202 |
| 109 | T cell proliferation (GO:0042098) | 2.72657308 |
| 110 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.72498352 |
| 111 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.72294723 |
| 112 | regulation of beta-amyloid formation (GO:1902003) | 2.72069875 |
| 113 | T cell receptor signaling pathway (GO:0050852) | 2.71897311 |
| 114 | regulation of regulatory T cell differentiation (GO:0045589) | 2.71648525 |
| 115 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.71432593 |
| 116 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.71207945 |
| 117 | germinal center formation (GO:0002467) | 2.71166674 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70011839 |
| 119 | negative regulation of type 2 immune response (GO:0002829) | 2.69083460 |
| 120 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.67612963 |
| 121 | protein localization to chromosome, centromeric region (GO:0071459) | 2.63569592 |
| 122 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.62644111 |
| 123 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.61605789 |
| 124 | low-density lipoprotein particle clearance (GO:0034383) | 2.59803764 |
| 125 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.59715598 |
| 126 | negative regulation of phagocytosis (GO:0050765) | 2.59350358 |
| 127 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.58603042 |
| 128 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.55963123 |
| 129 | DNA strand elongation (GO:0022616) | 2.55835655 |
| 130 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52863891 |
| 131 | imidazole-containing compound metabolic process (GO:0052803) | 2.52246817 |
| 132 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.50730901 |
| 133 | negative regulation of mRNA metabolic process (GO:1903312) | 2.48846672 |
| 134 | negative regulation of mRNA processing (GO:0050686) | 2.46105302 |
| 135 | negative regulation of RNA splicing (GO:0033119) | 2.46047631 |
| 136 | nucleobase biosynthetic process (GO:0046112) | 2.45000158 |
| 137 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.44451364 |
| 138 | UMP metabolic process (GO:0046049) | 2.44451364 |
| 139 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.44451364 |
| 140 | UMP biosynthetic process (GO:0006222) | 2.44451364 |
| 141 | histone mRNA catabolic process (GO:0071044) | 2.44169719 |
| 142 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.42928056 |
| 143 | positive regulation of histone deacetylation (GO:0031065) | 2.42198128 |
| 144 | regulation of protein heterodimerization activity (GO:0043497) | 2.39708566 |
| 145 | negative regulation of interleukin-12 production (GO:0032695) | 2.39281734 |
| 146 | mitotic recombination (GO:0006312) | 2.38577585 |
| 147 | serine family amino acid biosynthetic process (GO:0009070) | 2.38345202 |
| 148 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38156555 |
| 149 | regulation of DNA damage checkpoint (GO:2000001) | 2.36860023 |
| 150 | positive regulation of immune response to tumor cell (GO:0002839) | 2.36647193 |
| 151 | regulation of immune response to tumor cell (GO:0002837) | 2.36647193 |
| 152 | regulation of response to tumor cell (GO:0002834) | 2.36647193 |
| 153 | positive regulation of response to tumor cell (GO:0002836) | 2.36647193 |
| 154 | urea metabolic process (GO:0019627) | 2.36553294 |
| 155 | urea cycle (GO:0000050) | 2.36553294 |
| 156 | regulation of translational termination (GO:0006449) | 2.36155868 |
| 157 | organ regeneration (GO:0031100) | 2.32398631 |
| 158 | chromatin assembly (GO:0031497) | 2.30761751 |
| 159 | pteridine-containing compound metabolic process (GO:0042558) | 2.28394007 |
| 160 | leukocyte aggregation (GO:0070486) | 2.28263013 |
| 161 | peptidyl-lysine dimethylation (GO:0018027) | 2.27427852 |
| 162 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.27375796 |
| 163 | alpha-linolenic acid metabolic process (GO:0036109) | 2.25718675 |
| 164 | telomere maintenance via telomere lengthening (GO:0010833) | 2.25007930 |
| 165 | telomere maintenance via recombination (GO:0000722) | 2.24886696 |
| 166 | negative regulation of fibrinolysis (GO:0051918) | 2.24667561 |
| 167 | regulation of DNA endoreduplication (GO:0032875) | 2.23294111 |
| 168 | negative regulation of granulocyte differentiation (GO:0030853) | 2.23249646 |
| 169 | cell adhesion mediated by integrin (GO:0033627) | 2.23060407 |
| 170 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.22503338 |
| 171 | regulation of histone H3-K9 methylation (GO:0051570) | 2.21994109 |
| 172 | necroptotic process (GO:0070266) | 2.21831150 |
| 173 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.21828771 |
| 174 | DNA conformation change (GO:0071103) | 2.21770527 |
| 175 | mitotic G1/S transition checkpoint (GO:0044819) | 2.21547365 |
| 176 | regulation of mitotic spindle organization (GO:0060236) | 2.21066570 |
| 177 | negative regulation of histone methylation (GO:0031061) | 2.20185805 |
| 178 | DNA replication checkpoint (GO:0000076) | 2.20173897 |
| 179 | intestinal cholesterol absorption (GO:0030299) | 2.19978696 |
| 180 | Golgi transport vesicle coating (GO:0048200) | 2.18505200 |
| 181 | COPI coating of Golgi vesicle (GO:0048205) | 2.18505200 |
| 182 | regulation of spindle organization (GO:0090224) | 2.18183642 |
| 183 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.18182853 |
| 184 | tRNA aminoacylation for protein translation (GO:0006418) | 2.18180247 |
| 185 | nuclear envelope organization (GO:0006998) | 2.17920639 |
| 186 | L-serine metabolic process (GO:0006563) | 2.17465935 |
| 187 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.16668770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.31860738 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.35506997 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.71537988 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.99570948 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.95061587 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93843071 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.79548427 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.75264699 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.73388400 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.72941089 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.68911085 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.62738733 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42985746 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.28049508 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27353300 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.25588218 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23026526 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.10353734 |
| 19 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.04448953 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04023275 |
| 21 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03963030 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.01130415 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94555741 |
| 24 | * MAF_26560356_Chip-Seq_TH2_Human | 1.90757226 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88960619 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.88849550 |
| 27 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.87846707 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.80482007 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79728385 |
| 30 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.78253292 |
| 31 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.75516013 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74865353 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69325350 |
| 34 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69223945 |
| 35 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68014181 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.67577289 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67138744 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65456775 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.64972899 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62029446 |
| 41 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58535107 |
| 42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58241385 |
| 43 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.57383167 |
| 44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.56105885 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.55486382 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.55000234 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51244468 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.51145889 |
| 49 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.50180228 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50006247 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49792540 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48934883 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48568342 |
| 54 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.48354765 |
| 55 | * MYB_26560356_Chip-Seq_TH2_Human | 1.46079733 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45959783 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41991146 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41319336 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40274045 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39317259 |
| 61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38413324 |
| 62 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.36930487 |
| 63 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.35329319 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35171557 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33314025 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30005456 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29833795 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27799621 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27701749 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26560335 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26489316 |
| 72 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.26009560 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25328172 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24308206 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23632646 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22085209 |
| 77 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.21205332 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20913826 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19731282 |
| 80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19146575 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17843975 |
| 82 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17702656 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16476542 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16204018 |
| 85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16156764 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15995251 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15811953 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15749763 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14742308 |
| 90 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13111817 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13078968 |
| 92 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10982518 |
| 93 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09866473 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08575424 |
| 95 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.06525098 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06420618 |
| 97 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.05714155 |
| 98 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05713935 |
| 99 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02739817 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02540626 |
| 101 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01982915 |
| 102 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01015534 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99368875 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98749409 |
| 105 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.97861163 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97718314 |
| 107 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97512034 |
| 108 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97067445 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96481763 |
| 110 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.96444247 |
| 111 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95892038 |
| 112 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95521542 |
| 113 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95192169 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94388804 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94070477 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93734331 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93685661 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93259360 |
| 119 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.92692733 |
| 120 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.91784015 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91295900 |
| 122 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91219331 |
| 123 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91208177 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91038933 |
| 125 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90718913 |
| 126 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89898515 |
| 127 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.89416226 |
| 128 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88992068 |
| 129 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88959590 |
| 130 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88938575 |
| 131 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88423610 |
| 132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88010375 |
| 133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88005729 |
| 134 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87401982 |
| 135 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85786936 |
| 136 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85758786 |
| 137 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.85686181 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85161103 |
| 139 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84438585 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84128219 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83215556 |
| 142 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78436892 |
| 143 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77087948 |
| 144 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76855048 |
| 145 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73139828 |
| 146 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72485139 |
| 147 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.71387667 |
| 148 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71155308 |
| 149 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70897240 |
| 150 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70053097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.53163113 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 3.00455346 |
| 3 | MP0002009_preneoplasia | 2.94473364 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.70894700 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.65587351 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.58617967 |
| 7 | MP0008260_abnormal_autophagy | 2.57759043 |
| 8 | MP0005365_abnormal_bile_salt | 2.54673309 |
| 9 | MP0006082_CNS_inflammation | 2.53322358 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.48763260 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.37491008 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.36898499 |
| 13 | MP0005360_urolithiasis | 2.15634520 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.15133262 |
| 15 | MP0003221_abnormal_cardiomyocyte_apopto | 2.12035955 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 2.10305335 |
| 17 | MP0010307_abnormal_tumor_latency | 2.06661377 |
| 18 | MP0005083_abnormal_biliary_tract | 2.06476108 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 2.04412879 |
| 20 | MP0003828_pulmonary_edema | 1.95391827 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.93199758 |
| 22 | MP0003303_peritoneal_inflammation | 1.88594126 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.85743106 |
| 24 | MP0004808_abnormal_hematopoietic_stem | 1.85646581 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.85335619 |
| 26 | MP0003436_decreased_susceptibility_to | 1.79760343 |
| 27 | MP0000858_altered_metastatic_potential | 1.78834656 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.77927832 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.77675859 |
| 30 | MP0003077_abnormal_cell_cycle | 1.76668412 |
| 31 | MP0000685_abnormal_immune_system | 1.76375927 |
| 32 | MP0004957_abnormal_blastocyst_morpholog | 1.73863444 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.72035737 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.63845841 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.62601659 |
| 36 | MP0000490_abnormal_crypts_of | 1.60828582 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.57004857 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.54407737 |
| 39 | MP0001800_abnormal_humoral_immune | 1.52983190 |
| 40 | MP0002398_abnormal_bone_marrow | 1.51071578 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.49897882 |
| 42 | MP0004883_abnormal_blood_vessel | 1.48441725 |
| 43 | MP0001873_stomach_inflammation | 1.45654494 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.41599723 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.41599723 |
| 46 | MP0003252_abnormal_bile_duct | 1.40598642 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.40346434 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.39964570 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.37756787 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.37101106 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.37090857 |
| 52 | MP0002006_tumorigenesis | 1.36548351 |
| 53 | MP0002722_abnormal_immune_system | 1.36380463 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.36233200 |
| 55 | MP0008057_abnormal_DNA_replication | 1.35716372 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.35500323 |
| 57 | MP0009840_abnormal_foam_cell | 1.35485325 |
| 58 | MP0000609_abnormal_liver_physiology | 1.34519349 |
| 59 | MP0009278_abnormal_bone_marrow | 1.32994174 |
| 60 | MP0005023_abnormal_wound_healing | 1.32582329 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.31265634 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.29079813 |
| 63 | MP0003866_abnormal_defecation | 1.29048643 |
| 64 | MP0000371_diluted_coat_color | 1.28947657 |
| 65 | MP0005451_abnormal_body_composition | 1.28921130 |
| 66 | MP0003787_abnormal_imprinting | 1.27616785 |
| 67 | MP0004947_skin_inflammation | 1.25444533 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.23997336 |
| 69 | MP0003690_abnormal_glial_cell | 1.23299693 |
| 70 | MP0002419_abnormal_innate_immunity | 1.22496724 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.21270726 |
| 72 | MP0008058_abnormal_DNA_repair | 1.21266300 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.21222690 |
| 74 | MP0001819_abnormal_immune_cell | 1.19869879 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 1.19636184 |
| 76 | MP0000716_abnormal_immune_system | 1.18474354 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.18465278 |
| 78 | MP0001666_abnormal_nutrient_absorption | 1.16813211 |
| 79 | MP0002723_abnormal_immune_serum | 1.16414279 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 1.15998776 |
| 81 | MP0001915_intracranial_hemorrhage | 1.15919361 |
| 82 | MP0003329_amyloid_beta_deposits | 1.14724235 |
| 83 | MP0002429_abnormal_blood_cell | 1.13780749 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.13386850 |
| 85 | MP0004197_abnormal_fetal_growth/weight/ | 1.12087699 |
| 86 | MP0002405_respiratory_system_inflammati | 1.11926144 |
| 87 | MP0005310_abnormal_salivary_gland | 1.10312997 |
| 88 | MP0005387_immune_system_phenotype | 1.10149272 |
| 89 | MP0001790_abnormal_immune_system | 1.10149272 |
| 90 | MP0001851_eye_inflammation | 1.09208175 |
| 91 | MP0005671_abnormal_response_to | 1.09033187 |
| 92 | MP0001730_embryonic_growth_arrest | 1.08810050 |
| 93 | MP0002086_abnormal_extraembryonic_tissu | 1.08417054 |
| 94 | MP0005025_abnormal_response_to | 1.08100588 |
| 95 | MP0005000_abnormal_immune_tolerance | 1.07346428 |
| 96 | MP0009785_altered_susceptibility_to | 1.05641910 |
| 97 | MP0001853_heart_inflammation | 1.05181026 |
| 98 | MP0000598_abnormal_liver_morphology | 1.04493940 |
| 99 | MP0003868_abnormal_feces_composition | 1.04174273 |
| 100 | MP0003091_abnormal_cell_migration | 1.03533783 |
| 101 | MP0004484_altered_response_of | 1.03369467 |
| 102 | MP0005670_abnormal_white_adipose | 1.03048895 |
| 103 | MP0006054_spinal_hemorrhage | 1.02954189 |
| 104 | MP0003448_altered_tumor_morphology | 1.01126322 |
| 105 | MP0000604_amyloidosis | 1.00944055 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 1.00683836 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 1.00166227 |
| 108 | MP0000733_abnormal_muscle_development | 1.00078251 |
| 109 | MP0003045_fibrosis | 0.98081647 |
| 110 | MP0003123_paternal_imprinting | 0.97590797 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.96644835 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.94652127 |
| 113 | MP0009672_abnormal_birth_weight | 0.94633900 |
| 114 | MP0009763_increased_sensitivity_to | 0.93747197 |
| 115 | MP0001672_abnormal_embryogenesis/_devel | 0.92653830 |
| 116 | MP0005380_embryogenesis_phenotype | 0.92653830 |
| 117 | MP0000537_abnormal_urethra_morphology | 0.91516480 |
| 118 | MP0002088_abnormal_embryonic_growth/wei | 0.90708345 |
| 119 | MP0002080_prenatal_lethality | 0.90173587 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.90168657 |
| 121 | MP0003984_embryonic_growth_retardation | 0.90013955 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.88856203 |
| 123 | MP0005164_abnormal_response_to | 0.87569062 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.87438047 |
| 125 | MP0008004_abnormal_stomach_pH | 0.86581871 |
| 126 | MP0002148_abnormal_hypersensitivity_rea | 0.85164262 |
| 127 | MP0005621_abnormal_cell_physiology | 0.83607958 |
| 128 | MP0008469_abnormal_protein_level | 0.82054894 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.80052218 |
| 130 | MP0009053_abnormal_anal_canal | 0.80043724 |
| 131 | MP0004381_abnormal_hair_follicle | 0.78149932 |
| 132 | MP0004130_abnormal_muscle_cell | 0.76148201 |
| 133 | MP0005166_decreased_susceptibility_to | 0.74124664 |
| 134 | MP0003646_muscle_fatigue | 0.73027185 |
| 135 | MP0008874_decreased_physiological_sensi | 0.72106335 |
| 136 | MP0005384_cellular_phenotype | 0.70444458 |
| 137 | MP0005075_abnormal_melanosome_morpholog | 0.69577422 |
| 138 | MP0004185_abnormal_adipocyte_glucose | 0.68964326 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.68198424 |
| 140 | MP0001270_distended_abdomen | 0.66641581 |
| 141 | MP0009764_decreased_sensitivity_to | 0.65967212 |
| 142 | MP0003632_abnormal_nervous_system | 0.65411313 |
| 143 | MP0005645_abnormal_hypothalamus_physiol | 0.59617462 |
| 144 | MP0004811_abnormal_neuron_physiology | 0.59461186 |
| 145 | MP0004233_abnormal_muscle_weight | 0.58119550 |
| 146 | MP0005376_homeostasis/metabolism_phenot | 0.56053171 |
| 147 | MP0000249_abnormal_blood_vessel | 0.53630426 |
| 148 | MP0002928_abnormal_bile_duct | 0.53533183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.88427496 |
| 2 | Spontaneous hematomas (HP:0007420) | 3.84610094 |
| 3 | Gastrointestinal infarctions (HP:0005244) | 3.70803651 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.36126873 |
| 5 | Recurrent skin infections (HP:0001581) | 3.19047317 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 3.10692935 |
| 7 | Myositis (HP:0100614) | 3.10675887 |
| 8 | Abnormal platelet volume (HP:0011876) | 3.06729916 |
| 9 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.05163008 |
| 10 | Increased mean platelet volume (HP:0011877) | 2.99787701 |
| 11 | Gingivitis (HP:0000230) | 2.97560405 |
| 12 | Meningitis (HP:0001287) | 2.82717746 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 2.81600311 |
| 14 | Optic neuritis (HP:0100653) | 2.81600311 |
| 15 | Orchitis (HP:0100796) | 2.72366364 |
| 16 | Encephalitis (HP:0002383) | 2.62989659 |
| 17 | Urticaria (HP:0001025) | 2.60755465 |
| 18 | Stomatitis (HP:0010280) | 2.59512078 |
| 19 | Recurrent viral infections (HP:0004429) | 2.59039372 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53328011 |
| 21 | Vasculitis (HP:0002633) | 2.51641478 |
| 22 | Chest pain (HP:0100749) | 2.51328722 |
| 23 | Spastic diplegia (HP:0001264) | 2.48736814 |
| 24 | T lymphocytopenia (HP:0005403) | 2.42453895 |
| 25 | Slow saccadic eye movements (HP:0000514) | 2.42166226 |
| 26 | Lower limb hyperreflexia (HP:0002395) | 2.39343594 |
| 27 | Acute hepatic failure (HP:0006554) | 2.37551162 |
| 28 | Cellulitis (HP:0100658) | 2.34236293 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33688339 |
| 30 | Obstructive lung disease (HP:0006536) | 2.33688339 |
| 31 | Fatigue (HP:0012378) | 2.33262137 |
| 32 | Abnormality of the thoracic spine (HP:0100711) | 2.30272649 |
| 33 | Deep venous thrombosis (HP:0002625) | 2.30033431 |
| 34 | Papilledema (HP:0001085) | 2.28668817 |
| 35 | Abnormality of T cells (HP:0002843) | 2.26011226 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.25838543 |
| 37 | Selective tooth agenesis (HP:0001592) | 2.25061571 |
| 38 | IgM deficiency (HP:0002850) | 2.24776003 |
| 39 | Osteomyelitis (HP:0002754) | 2.24408290 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.24034798 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24034798 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.23501087 |
| 43 | Thrombocytosis (HP:0001894) | 2.22728903 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21527782 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21527782 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21527782 |
| 47 | Ankle clonus (HP:0011448) | 2.20987160 |
| 48 | Abnormality of T cell number (HP:0011839) | 2.20424274 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.18505408 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17994671 |
| 51 | Cervical subluxation (HP:0003308) | 2.16114959 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.15906031 |
| 53 | Papillary thyroid carcinoma (HP:0002895) | 2.14642102 |
| 54 | Global brain atrophy (HP:0002283) | 2.13202849 |
| 55 | Hepatitis (HP:0012115) | 2.11632038 |
| 56 | Protrusio acetabuli (HP:0003179) | 2.11211849 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10572886 |
| 58 | Dilatation of the ascending aorta (HP:0005111) | 2.09252385 |
| 59 | Lymphopenia (HP:0001888) | 2.08287457 |
| 60 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.07923702 |
| 61 | Myocardial infarction (HP:0001658) | 2.07824452 |
| 62 | Birth length less than 3rd percentile (HP:0003561) | 2.06980077 |
| 63 | Chromsome breakage (HP:0040012) | 2.06799734 |
| 64 | Sparse lateral eyebrow (HP:0005338) | 2.06624460 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.06227556 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.06078004 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.03875587 |
| 68 | Papilloma (HP:0012740) | 2.02317167 |
| 69 | Verrucae (HP:0200043) | 2.02317167 |
| 70 | Hyperacusis (HP:0010780) | 2.01453172 |
| 71 | Polycythemia (HP:0001901) | 2.00659115 |
| 72 | Deviation of the thumb (HP:0009603) | 2.00357485 |
| 73 | Resting tremor (HP:0002322) | 1.99997448 |
| 74 | Ureteral obstruction (HP:0006000) | 1.99583783 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 1.99100432 |
| 76 | Pulmonary embolism (HP:0002204) | 1.98798926 |
| 77 | Increased density of long bones (HP:0006392) | 1.98664327 |
| 78 | Cerebral aneurysm (HP:0004944) | 1.96478126 |
| 79 | Radial bowing (HP:0002986) | 1.94561878 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94320071 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 1.92795792 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 1.92286015 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92021403 |
| 84 | Hemoptysis (HP:0002105) | 1.91729073 |
| 85 | Periodontitis (HP:0000704) | 1.91550508 |
| 86 | Chronic diarrhea (HP:0002028) | 1.91535007 |
| 87 | Hypobetalipoproteinemia (HP:0003563) | 1.91265529 |
| 88 | Ureteral stenosis (HP:0000071) | 1.91236451 |
| 89 | Pheochromocytoma (HP:0002666) | 1.90721324 |
| 90 | Genu recurvatum (HP:0002816) | 1.90553789 |
| 91 | Abnormality of the fingertips (HP:0001211) | 1.90196972 |
| 92 | Microcytic anemia (HP:0001935) | 1.90088051 |
| 93 | Lip pit (HP:0100267) | 1.89801568 |
| 94 | Scanning speech (HP:0002168) | 1.88861407 |
| 95 | Viral hepatitis (HP:0006562) | 1.87933127 |
| 96 | Keratoconjunctivitis (HP:0001096) | 1.87300448 |
| 97 | Pulmonary infiltrates (HP:0002113) | 1.86171704 |
| 98 | Aortic aneurysm (HP:0004942) | 1.85877116 |
| 99 | Gingival bleeding (HP:0000225) | 1.85482666 |
| 100 | Chronic otitis media (HP:0000389) | 1.85255902 |
| 101 | Peritonitis (HP:0002586) | 1.85203016 |
| 102 | Granulocytopenia (HP:0001913) | 1.84543557 |
| 103 | Combined immunodeficiency (HP:0005387) | 1.83101638 |
| 104 | Ependymoma (HP:0002888) | 1.83090827 |
| 105 | Proximal placement of thumb (HP:0009623) | 1.82738618 |
| 106 | Urinary urgency (HP:0000012) | 1.82692198 |
| 107 | Gastrointestinal stroma tumor (HP:0100723) | 1.81895187 |
| 108 | Progressive neurologic deterioration (HP:0002344) | 1.81791322 |
| 109 | Thickened calvaria (HP:0002684) | 1.81692065 |
| 110 | Abnormality of the common coagulation pathway (HP:0010990) | 1.81673348 |
| 111 | Hypoglycemic seizures (HP:0002173) | 1.81523556 |
| 112 | Absent speech (HP:0001344) | 1.80227519 |
| 113 | Gastrointestinal inflammation (HP:0004386) | 1.79992734 |
| 114 | Leukocytosis (HP:0001974) | 1.79476322 |
| 115 | Colitis (HP:0002583) | 1.79436005 |
| 116 | Renovascular hypertension (HP:0100817) | 1.79324380 |
| 117 | Bowel diverticulosis (HP:0005222) | 1.78456196 |
| 118 | Mitral valve prolapse (HP:0001634) | 1.78280281 |
| 119 | Joint swelling (HP:0001386) | 1.77400892 |
| 120 | Ankle contracture (HP:0006466) | 1.75453482 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.75153745 |
| 122 | Recurrent cutaneous fungal infections (HP:0011370) | 1.75153745 |
| 123 | Amaurosis fugax (HP:0100576) | 1.74853103 |
| 124 | Ectopia lentis (HP:0001083) | 1.74488677 |
| 125 | Increased IgE level (HP:0003212) | 1.73372959 |
| 126 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72879704 |
| 127 | Basal cell carcinoma (HP:0002671) | 1.72868093 |
| 128 | Arterial thrombosis (HP:0004420) | 1.72511681 |
| 129 | Inflammation of the large intestine (HP:0002037) | 1.71210777 |
| 130 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.70205548 |
| 131 | Neuronal loss in central nervous system (HP:0002529) | 1.69858902 |
| 132 | Abnormality of the astrocytes (HP:0100707) | 1.69606324 |
| 133 | Astrocytoma (HP:0009592) | 1.69606324 |
| 134 | Difficulty running (HP:0009046) | 1.69317205 |
| 135 | Epistaxis (HP:0000421) | 1.69013619 |
| 136 | Autoimmune thrombocytopenia (HP:0001973) | 1.68353936 |
| 137 | Shallow orbits (HP:0000586) | 1.67231710 |
| 138 | IgA deficiency (HP:0002720) | 1.66944161 |
| 139 | Xanthomatosis (HP:0000991) | 1.66459463 |
| 140 | Thoracic kyphosis (HP:0002942) | 1.66088421 |
| 141 | Abnormal foot bone ossification (HP:0010675) | 1.66077189 |
| 142 | Prominent nose (HP:0000448) | 1.65026729 |
| 143 | Abnormality of the calcaneus (HP:0008364) | 1.64378310 |
| 144 | Elfin facies (HP:0004428) | 1.64070552 |
| 145 | Intrahepatic cholestasis (HP:0001406) | 1.63652742 |
| 146 | Pseudobulbar signs (HP:0002200) | 1.62911264 |
| 147 | Hypoplasia of the thymus (HP:0000778) | 1.62561973 |
| 148 | Severe combined immunodeficiency (HP:0004430) | 1.61591470 |
| 149 | Abnormality of the lower motor neuron (HP:0002366) | 1.61398099 |
| 150 | Menorrhagia (HP:0000132) | 1.59692288 |
| 151 | Flat acetabular roof (HP:0003180) | 1.59644087 |
| 152 | Pustule (HP:0200039) | 1.59534684 |
| 153 | Absent frontal sinuses (HP:0002688) | 1.59269700 |
| 154 | Prolonged bleeding time (HP:0003010) | 1.58198386 |
| 155 | Oral leukoplakia (HP:0002745) | 1.57943248 |
| 156 | Joint hemorrhage (HP:0005261) | 1.57116700 |
| 157 | Interstitial pulmonary disease (HP:0006530) | 1.56296884 |
| 158 | Frequent falls (HP:0002359) | 1.56233205 |
| 159 | Severe short stature (HP:0003510) | 1.56181878 |
| 160 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.55806683 |
| 161 | Short 4th metacarpal (HP:0010044) | 1.55806683 |
| 162 | Abnormality of the intrinsic pathway (HP:0010989) | 1.55475939 |
| 163 | 11 pairs of ribs (HP:0000878) | 1.55222867 |
| 164 | High pitched voice (HP:0001620) | 1.54224200 |
| 165 | Complement deficiency (HP:0004431) | 1.53967252 |
| 166 | Recurrent bronchitis (HP:0002837) | 1.53790875 |
| 167 | Cutaneous melanoma (HP:0012056) | 1.52859292 |
| 168 | Agnosia (HP:0010524) | 1.52837990 |
| 169 | Eczematoid dermatitis (HP:0000976) | 1.52698120 |
| 170 | Abnormality of the peritoneum (HP:0002585) | 1.51624666 |
| 171 | Disinhibition (HP:0000734) | 1.50480709 |
| 172 | Recurrent bacterial skin infections (HP:0005406) | 1.49905239 |
| 173 | Abnormality of the anterior horn cell (HP:0006802) | 1.48612473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 3.43780939 |
| 2 | RIPK4 | 3.26486125 |
| 3 | EEF2K | 3.11026155 |
| 4 | CDK12 | 2.92456324 |
| 5 | PRPF4B | 2.69392895 |
| 6 | MAP4K1 | 2.60751249 |
| 7 | TRIB3 | 2.58436886 |
| 8 | FES | 2.48881323 |
| 9 | MAP3K10 | 2.37529117 |
| 10 | FLT3 | 2.29992683 |
| 11 | SIK3 | 2.24970726 |
| 12 | STK10 | 2.23587689 |
| 13 | CDC7 | 2.20944983 |
| 14 | SIK1 | 2.06136888 |
| 15 | EPHA2 | 2.02024765 |
| 16 | CAMKK2 | 1.99058467 |
| 17 | JAK3 | 1.93015115 |
| 18 | MAP3K6 | 1.88717342 |
| 19 | ACVR1B | 1.81246092 |
| 20 | KSR2 | 1.78100002 |
| 21 | ZAP70 | 1.73617534 |
| 22 | MAP3K2 | 1.69974993 |
| 23 | MAP3K3 | 1.68918719 |
| 24 | YES1 | 1.67139896 |
| 25 | TTN | 1.65831233 |
| 26 | TAOK3 | 1.52270481 |
| 27 | MAP3K13 | 1.51247911 |
| 28 | RPS6KB2 | 1.51245920 |
| 29 | STK24 | 1.49612573 |
| 30 | ERN1 | 1.47802289 |
| 31 | WEE1 | 1.44383503 |
| 32 | SIK2 | 1.42683616 |
| 33 | TYK2 | 1.41353326 |
| 34 | FGFR4 | 1.39171504 |
| 35 | FGR | 1.39007556 |
| 36 | CCNB1 | 1.37688635 |
| 37 | ATR | 1.36182717 |
| 38 | NEK2 | 1.34502076 |
| 39 | KSR1 | 1.34475147 |
| 40 | IRAK4 | 1.33528028 |
| 41 | MAP3K8 | 1.30452348 |
| 42 | RPS6KA4 | 1.29958445 |
| 43 | CAMK1D | 1.29364263 |
| 44 | BCR | 1.28401012 |
| 45 | TXK | 1.27050354 |
| 46 | PTK6 | 1.24534567 |
| 47 | GRK6 | 1.23115923 |
| 48 | RIPK1 | 1.22986827 |
| 49 | ERBB3 | 1.22724395 |
| 50 | CDK4 | 1.20931735 |
| 51 | CDK7 | 1.20683031 |
| 52 | CDK6 | 1.18338469 |
| 53 | BRD4 | 1.13584956 |
| 54 | PASK | 1.13270838 |
| 55 | LRRK2 | 1.12024719 |
| 56 | MAP3K5 | 1.09548566 |
| 57 | LYN | 1.06859607 |
| 58 | IRAK3 | 1.05594393 |
| 59 | BLK | 1.03153600 |
| 60 | ITK | 1.00483687 |
| 61 | BMPR2 | 0.99685466 |
| 62 | TAOK1 | 0.98000958 |
| 63 | SCYL2 | 0.95872959 |
| 64 | BTK | 0.94958084 |
| 65 | TGFBR1 | 0.94938763 |
| 66 | MTOR | 0.94922690 |
| 67 | ALK | 0.94818564 |
| 68 | PIM2 | 0.93885074 |
| 69 | MAP2K4 | 0.93100641 |
| 70 | MAPKAPK3 | 0.91243531 |
| 71 | MARK2 | 0.91078394 |
| 72 | TNK2 | 0.89689407 |
| 73 | JAK1 | 0.89431073 |
| 74 | TRPM7 | 0.88693643 |
| 75 | DYRK1B | 0.88141060 |
| 76 | MAP3K14 | 0.88128174 |
| 77 | NME2 | 0.86832454 |
| 78 | CAMKK1 | 0.84834933 |
| 79 | PAK2 | 0.83670903 |
| 80 | PIM1 | 0.83475401 |
| 81 | PDK1 | 0.82609218 |
| 82 | PAK4 | 0.81228008 |
| 83 | TEC | 0.80171125 |
| 84 | MAP3K4 | 0.78915883 |
| 85 | PDGFRA | 0.77152842 |
| 86 | CSF1R | 0.76998155 |
| 87 | TTK | 0.76933117 |
| 88 | TRIM28 | 0.74291012 |
| 89 | WNK1 | 0.73911845 |
| 90 | EPHB1 | 0.73192490 |
| 91 | AURKB | 0.72571944 |
| 92 | CSK | 0.71808809 |
| 93 | FGFR1 | 0.70932177 |
| 94 | RET | 0.70304914 |
| 95 | CHUK | 0.70248255 |
| 96 | EPHA3 | 0.69813708 |
| 97 | KIT | 0.69647387 |
| 98 | LCK | 0.69568179 |
| 99 | MAPK12 | 0.68990086 |
| 100 | BCKDK | 0.68895147 |
| 101 | MARK3 | 0.68080211 |
| 102 | MAP3K1 | 0.68071325 |
| 103 | TBK1 | 0.66946183 |
| 104 | PDGFRB | 0.66763784 |
| 105 | HCK | 0.66513470 |
| 106 | EIF2AK1 | 0.65821472 |
| 107 | NEK9 | 0.65459323 |
| 108 | MAPK11 | 0.65179051 |
| 109 | PLK1 | 0.64689870 |
| 110 | CAMK4 | 0.64602962 |
| 111 | IKBKE | 0.63594372 |
| 112 | STK4 | 0.61481146 |
| 113 | TESK2 | 0.61264527 |
| 114 | CHEK1 | 0.60959405 |
| 115 | MAP2K7 | 0.60805226 |
| 116 | EIF2AK2 | 0.60796028 |
| 117 | MAP2K3 | 0.59118868 |
| 118 | TGFBR2 | 0.58794063 |
| 119 | CDK19 | 0.58141527 |
| 120 | ATM | 0.57902304 |
| 121 | PIK3CG | 0.57718320 |
| 122 | PINK1 | 0.57266234 |
| 123 | FYN | 0.55880991 |
| 124 | RAF1 | 0.55645774 |
| 125 | FGFR3 | 0.54882481 |
| 126 | SYK | 0.54878070 |
| 127 | RPS6KB1 | 0.51859818 |
| 128 | TAOK2 | 0.51102467 |
| 129 | MAP3K7 | 0.50256547 |
| 130 | NTRK2 | 0.49666515 |
| 131 | PDPK1 | 0.49639508 |
| 132 | DAPK1 | 0.48881953 |
| 133 | EGFR | 0.48391065 |
| 134 | PTK2 | 0.48036992 |
| 135 | JAK2 | 0.47798266 |
| 136 | SRPK1 | 0.47583491 |
| 137 | BMX | 0.47557019 |
| 138 | RPS6KL1 | 0.47280964 |
| 139 | RPS6KC1 | 0.47280964 |
| 140 | CDC42BPA | 0.47103625 |
| 141 | CDK2 | 0.45674547 |
| 142 | MAPK7 | 0.45567537 |
| 143 | PRKCQ | 0.44757822 |
| 144 | CLK1 | 0.44346162 |
| 145 | CASK | 0.44204952 |
| 146 | TSSK6 | 0.44026943 |
| 147 | IRAK2 | 0.43382289 |
| 148 | NEK1 | 0.42849284 |
| 149 | CAMK1G | 0.41312646 |
| 150 | EIF2AK3 | 0.40506485 |
| 151 | IKBKB | 0.40200355 |
| 152 | TESK1 | 0.40112308 |
| 153 | STK38 | 0.39173865 |
| 154 | GRK7 | 0.37638528 |
| 155 | SGK3 | 0.35087657 |
| 156 | IRAK1 | 0.33500533 |
| 157 | CDK3 | 0.32399304 |
| 158 | RPS6KA6 | 0.32057486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.62366936 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.75189311 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.58284418 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.18989070 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 1.95662682 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84724222 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 1.76848110 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59911144 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50726602 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.47706740 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47328592 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 1.47109038 |
| 13 | Lysine degradation_Homo sapiens_hsa00310 | 1.45509331 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45155987 |
| 15 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.44651397 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43801653 |
| 17 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.42856215 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40302336 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.40131628 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39680050 |
| 21 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.39445532 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35743088 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35341181 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35103643 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32044031 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29648068 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29251442 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.28581615 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28243900 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27853744 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27703534 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27623852 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.24207463 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23389385 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.22488302 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21091520 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20877609 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20826539 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.19522066 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.16321091 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13102275 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12987006 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12194219 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11904798 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10958659 |
| 46 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.09512284 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09074050 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.08529710 |
| 49 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.08295889 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.05596741 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03661816 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02772953 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02743792 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00717656 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99223942 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.96711176 |
| 57 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95915968 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94217384 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.93231947 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92990491 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92790909 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.92512543 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92301764 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.92281013 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.91702584 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91107921 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90505327 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.90475215 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89881076 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.89308322 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88968689 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87459627 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.87134402 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85038162 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84861285 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84693094 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84098527 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83496854 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82472688 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82396951 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81912397 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81866876 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81553855 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.81034171 |
| 85 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80132344 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79993905 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79686832 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78225632 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78094982 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.77013403 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76671628 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76435044 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76023847 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75177796 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74719819 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74387054 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74106274 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73310895 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72418830 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.70547758 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68691690 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68042425 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67411345 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66682942 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.66555291 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66190163 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65900136 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65362401 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65237645 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.65113184 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.64882002 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64517917 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63529561 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63234731 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63045985 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62973571 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62266786 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62024337 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61506537 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61375498 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.60625465 |
| 122 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60314432 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58642818 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58315547 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58184791 |
| 126 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57685630 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57543889 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56762244 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56505117 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56255627 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56041068 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55795594 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55578398 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55408099 |
| 135 | Lysosome_Homo sapiens_hsa04142 | 0.54876679 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54461659 |
| 137 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54129007 |
| 138 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54092516 |
| 139 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53069455 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.53018053 |
| 141 | Asthma_Homo sapiens_hsa05310 | 0.52829369 |
| 142 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51721103 |
| 143 | Platelet activation_Homo sapiens_hsa04611 | 0.51369619 |
| 144 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51320062 |
| 145 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49064854 |
| 146 | Tuberculosis_Homo sapiens_hsa05152 | 0.48914917 |
| 147 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48451384 |
| 148 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47599045 |
| 149 | Prostate cancer_Homo sapiens_hsa05215 | 0.47222553 |
| 150 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46555076 |
| 151 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46536847 |
| 152 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45430653 |
| 153 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44645253 |
| 154 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44597859 |
| 155 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43634225 |

